This is a beta test.
Question: Whether it's right that we should choose different MSI locis for different cancer types if using NGS dectect MSI status?
Entering edit mode


As we know ,there has differenct MSI-H prevalence for different cancer types . So if we wanna use NGS method to detect MSI status of tumor samples, should we consider to pick particular and specific MSI loci combination for one specific cancer ? and why ?

Becasue different cancers have different driver genes , should we choose MSI loci within the range of driver genes ? and why ?

what's the best method to pick MSI loci to determine the tumor sample MSI-H status ?

Any help is welcome ! Thanks !

ADD COMMENTlink 6 months ago demolidd77 • 0 • updated 3 months ago Natay Aberra 0

Login before adding your answer.

Powered by the version 1.6